Remlifansirin
Search documents
ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference Transcript
2026-01-13 18:47
ACADIA Pharmaceuticals (NasdaqGS:ACAD) FY Conference January 13, 2026 12:45 PM ET Company ParticipantsElizabeth Thompson - Head of R&DCatherine Owen Adams - CEOThomas Garner - Chief Commercial OfficerMark Schneyer - CFOConference Call ParticipantsTessa Romero - Senior Biotech AnalystTessa RomeroWelcome, everyone, to the 44th Annual JPMorgan Healthcare Conference. My name is Tess Romero, and I'm one of the Senior Biotech Analysts here at JPMorgan. Our next presenting company is ACADIA Pharmaceuticals, and pr ...